Mechanistic description
Engineered decoy RNAs containing modified G4C2 repeats could sequester pathological RNA species and prevent their interference with normal RNP condensate formation.
Debate provenance: derived from debate sess_SDA-2026-04-11-sda-2026-04-01-gap-006 on question: TDP-43 phase separation therapeutics for ALS-FTD. Consensus signal: domain_expert, skeptic, synthesizer, theorist discussed the mechanism terms Decoy, G4C2, RNA, RNP, Therapeutics. Novelty signal: skeptic-discussed-with-qualified-concession.
Evidence for (1)
Evidence matrix
Cite this hypothesis
Cite this hypothesis
etl-backfill (2026). G4C2 RNA Decoy Therapeutics. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-debate-cc1a80961f99
@misc{scidex_hypothesis_hdebatec,
title = {G4C2 RNA Decoy Therapeutics},
author = {etl-backfill},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/h-debate-cc1a80961f99},
note = {SciDEX artifact hypothesis:h-debate-cc1a80961f99}
}